• Mashup Score: 1
    CRC incidence spikes between ages 49 and 50 years - 4 year(s) ago

    A steep increase in incidence of colorectal cancer among patients aged between 49 and 50 years may suggest that many cases go undetected in younger patients before they reach routine, average-risk screening at age 50 years, according to data published in JAMA Network Open. “Given the current debate over colorectal cancer screening at age 45 vs. 50, we felt it would be revealing to conduct

    Source: www.healio.com
    Categories: Gastroenterology
    Tweet Tweets with this article
    • Profile photo of AmCollegeGastro
      AmCollegeGastro

      CRC incidence spikes between ages 49 and 50 years https://t.co/OydLlNwlkI

  • Mashup Score: 0
    Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vacc | CIA - 4 year(s) ago

    Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance – Relationship With Selected Immune And Clinical Parameters Marcin Pasiarski,1,2 Barbara Sosnowska-Pasiarska,3 Ewelina Grywalska,4,5 Agnieszka Stelmach-Gołdyś,1 Artur Kowalik,6 Stanisław Góźdź,2,7 Jacek Roliński4,5 1Department of Hematology, Holycross…

    Source: www.dovepress.com
    Categories: Hem/Oncs
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Immunogenicity and Safety Of The 13-Valent Pneumococcal Conjugate Vaccine [PCV13] In Patients with MGUS – Relationship with Selected Immune And Clinical Parameters [Oct 9, 2019] Pasiarski et al. Clinical Interventions in Aging https://t.co/sj46MHQr3G #mmsm #IDonc https://t.co/FPldZqGg8S

  • Mashup Score: 1
    Opinion | Pharma to the Rescue - 4 year(s) ago

    Advances in drug research mean a vaccine for the coronavirus could be in human trials by April.

    Source: WSJ
    Categories: Cardiologists
    Tweet Tweets with this article
    • Profile photo of yaleHFdoc
      yaleHFdoc

      Pharma to the rescue: Advances in drug research mean a vaccine for the coronavirus could be in human trials by April https://t.co/HAFbp5Ii2d

  • Mashup Score: 0
    RENAL SBRT – EVIDENCE, PATIENT SELECTION AND OUTCOMES - 4 year(s) ago

    Rod J Ellis, M.D. FACRO Professor and Chair Radiation Oncology Penn State University Milton Hershey Medical Center Hershey Pennsylvania discusses RENAL SBRT – EVIDENCE, PATIENT SELECTION AND OUTCOMES at the 18th International Kidney Cancer Symposium 2019, Miami, FL.

    Source: www.oncologytube.com
    Categories: Hem/Onc News and Journals
    Tweet Tweets with this article
    • Profile photo of oncologytube
      oncologytube

      RENAL SBRT – EVIDENCE, PATIENT SELECTION AND OUTCOMES: Rod J Ellis, M.D. FACRO Professor and Chair Radiation Oncology Penn State University Milton Hershey Medical Center Hershey Pennsylvania discusses RENAL SBRT – EVIDENCE, PATIENT SELECTION AND OUTCOMES… https://t.co/t68Jirl2L6 https://t.co/SekHalbzAb

  • Mashup Score: 0
    98.6 Degrees Fahrenheit Isn’t the Average Anymore - 4 year(s) ago

    For nearly 150 years, 98.6 degrees Fahrenheit has been the accepted standard temperature for the human body. But at least two dozen modern studies have concluded the number is too high.

    Source: WSJ
    Categories: Cardiologists
    Tweet Tweets with this article
    • Profile photo of yaleHFdoc
      yaleHFdoc

      Say goodbye to 98.6 degrees Fahrenheit. The human body has been cooling over time. https://t.co/sa4xg4s2r4

  • Mashup Score: 0
    LAP Mentor | Simbionix - 4 year(s) ago

    The Simbionix LAP Mentor stands out amongst available laparoscopic surgical simulators by providing a complete training solution to learners

    Source: simbionix.com
    Categories: Future of Medicine
    Tweet Tweets with this article
    • Profile photo of SimbionixUSA
      SimbionixUSA

      It is fun to see how excited people get when they experience the Simbionix LAP Mentor https://t.co/OM78PI38K8. #laparoscopy #simulation https://t.co/Ziy4KIAJIO

Load More